UCI MIND leading new training for scientists on Alzheimer’s clinical trials

The University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) is leading a new annual multi-day course on clinical trials in Alzheimer’s disease and related dementias.

Josh Grill
Photo: Steve Zylius/UCI

The course will be directed by Joshua Grill, PhD, Director of UCI MIND and Rema Raman, PhD, a professor of neurology at the Keck School and the Director of Biostatistics at USC Alzheimer’s Therapeutic Research Institute (ATRI). Other course faculty members include UCI MIND researchers Daniel Gillen, PhD and David Sultzer, MD.

The launch of the training program, called IMPACT-AD, is designed to educate and promote diversity among researchers and future principal investigators in the field of Alzheimer’s Disease and Related Disorders (ADRD).

“We want to train the next generation of researchers conducting clinical trials,” Grill said. “Diversity among scientists helps diversify the population of people volunteering to participate in clinical trials, which in turn improves the quality of the science.”

The initiative is funded for $4 million over five years. The funding comes from the National Institute on Aging and the Alzheimer’s Association.

The course will be offered annually. Enrollment for this year is already full.